Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer DOI Creative Commons
Jaewang Lee,

Ji Hyeon You,

Minsu Kim

et al.

Redox Biology, Journal Year: 2020, Volume and Issue: 37, P. 101697 - 101697

Published: Aug. 28, 2020

Ferroptosis is a newly defined form of cell death induced by iron-dependent accumulation lethal lipid peroxidation. represent therapeutic strategy to suppress therapy-resistant cancer cells with more property epithelial-mesenchymal transition (EMT). However, epigenetic reprogramming EMT has been rarely studied in the context ferroptosis susceptibility. Therefore, we examined potentiality promoting head and neck (HNC) cells. The effects inducers inhibition or induction were tested HNC lines mouse tumor xenograft models. These analyzed concerning viability death, reactive oxygen species iron production, labile pool, glutathione contents, NAD/NADH levels, mRNA/protein expression. Cell density expression levels E-cadherin, vimentin, ZEB1 associated different susceptibility inducers. CDH1 silencing overexpression increased ferroptosis, whereas CDH decreased susceptibility, vitro vivo. Histone deacetylase SIRT1 gene pharmacological EX-527 suppressed consequently SIRT inducers, resveratrol SRT1720, ferroptosis. MiR-200 family inhibitors In low treatment 5-azacitidine diminished hypermethylation CDH1, resulting E-cadherin Our data suggest that contributes

Language: Английский

EMT: 2016 DOI Creative Commons
M. Ángela Nieto, Ruby Yun‐Ju Huang, Rebecca Jackson

et al.

Cell, Journal Year: 2016, Volume and Issue: 166(1), P. 21 - 45

Published: June 1, 2016

Language: Английский

Citations

3854

EMT Transition States during Tumor Progression and Metastasis DOI
Ievgenia Pastushenko, Cédric Blanpain

Trends in Cell Biology, Journal Year: 2018, Volume and Issue: 29(3), P. 212 - 226

Published: Dec. 26, 2018

Language: Английский

Citations

2351

Identification of the tumour transition states occurring during EMT DOI
Ievgenia Pastushenko, Audrey Brisebarre, Alejandro Sifrim

et al.

Nature, Journal Year: 2018, Volume and Issue: 556(7702), P. 463 - 468

Published: April 1, 2018

Language: Английский

Citations

1306

TGF-β1 Signaling and Tissue Fibrosis DOI Open Access
Kevin K. Kim, Dean Sheppard, Harold A. Chapman

et al.

Cold Spring Harbor Perspectives in Biology, Journal Year: 2017, Volume and Issue: 10(4), P. a022293 - a022293

Published: April 21, 2017

Kevin K. Kim1, Dean Sheppard2 and Harold A. Chapman2 1Department of Medicine, University Michigan School Ann Arbor, 48109 2Department Cardiovascular Research Institute, Lung Biology Center, California, San Francisco, California 94143 Correspondence: hal.chapman{at}ucsf.edu

Language: Английский

Citations

595

Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance DOI Creative Commons

Piyush B. Gupta,

Ievgenia Pastushenko,

Adam Skibinski

et al.

Cell stem cell, Journal Year: 2018, Volume and Issue: 24(1), P. 65 - 78

Published: Dec. 13, 2018

Language: Английский

Citations

505

Epithelial–mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis DOI
Tong Chen,

Yanan You,

Hua Jiang

et al.

Journal of Cellular Physiology, Journal Year: 2017, Volume and Issue: 232(12), P. 3261 - 3272

Published: Jan. 13, 2017

The lineage transition between epithelium and mesenchyme is a process known as epithelial–mesenchymal (EMT), by which polarized epithelial cells lose their adhesion property obtain mesenchymal cell phenotypes. EMT biological that often involved in embryogenesis diseases, such cancer invasion metastasis. the reverse process, mesenchymal–epithelial (MET), also play important roles stem differentiation de‐differentiation (or reprogramming). In this review, we will discuss current research progress of embryonic development, cellular reprogramming, progression, all are representative models for researches biology normal diseases. Understanding MET may help to identify specific markers distinguish from future.

Language: Английский

Citations

487

Tumor Budding: The Name is EMT. Partial EMT. DOI Open Access

Alexandru Dan Grigore,

Mohit Kumar Jolly, Dongya Jia

et al.

Journal of Clinical Medicine, Journal Year: 2016, Volume and Issue: 5(5), P. 51 - 51

Published: April 29, 2016

Tumor budding is a histological phenomenon encountered in various cancers, whereby individual malignant cells and/or small clusters of are seen the tumor stroma. Postulated to be mirror epithelial-mesenchymal transition, has been associated with poor cancer outcomes. However, vast heterogeneity its exact definition, methodology assessment, and patient stratification need resolved before it can routinely used as standardized prognostic feature. Here, we discuss defining assessing budding, clinical significance across multiple types, prospective implementation practice. Next, review emerging evidence about partial, rather than complete, phenotype at bud level, connection proliferation, quiescence, stemness. Finally, based on recent literature, indicating co-expression epithelial mesenchymal markers many buds, posit manifestation this hybrid epithelial/mesenchymal displaying collective cell migration.

Language: Английский

Citations

460

Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells DOI Creative Commons

Cornelia Kröger,

Alexander B. Afeyan,

Jasmin Mraz

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2019, Volume and Issue: 116(15), P. 7353 - 7362

Published: March 25, 2019

Carcinoma cells residing in an intermediate phenotypic state along the epithelial–mesenchymal (E–M) spectrum are associated with malignant phenotypes, such as invasiveness, tumor-initiating ability, and metastatic dissemination. Using recently described CD104 + /CD44 hi antigen marker combination, we isolated highly tumorigenic breast cancer stably—both vitro vivo—in coexpressing both epithelial (E) mesenchymal (M) markers. We demonstrate that tumorigenicity depends on individual this E/M hybrid cannot be phenocopied by mixing two cell populations reside stably at ends of spectrum, i.e., E M state. Hence, residence a specific E–M rather than plasticity appears critical to expression capacity. Acquisition is facilitated differential EMT-inducing transcription factors (EMT-TFs) accompanied adult stem programs, notably, active canonical Wnt signaling. Furthermore, transition from fully phenotype, achieved constitutive ectopic Zeb1, sufficient drive out into state, which substantial loss switch noncanonical Identifying gatekeepers various states arrayed likely prove useful developing therapeutic approaches operate shifting between distinct spectrum.

Language: Английский

Citations

457

Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe? DOI Creative Commons

Maren Diepenbruck,

Gerhard Christofori

Current Opinion in Cell Biology, Journal Year: 2016, Volume and Issue: 43, P. 7 - 13

Published: June 29, 2016

Language: Английский

Citations

442

Controversies around epithelial–mesenchymal plasticity in cancer metastasis DOI
Elizabeth D. Williams, Dingcheng Gao, Andrew Redfern

et al.

Nature reviews. Cancer, Journal Year: 2019, Volume and Issue: 19(12), P. 716 - 732

Published: Oct. 30, 2019

Language: Английский

Citations

380